The effects of budesonide therapy on airway hypersecretion and/or sputum excretion failure in asthma patients; open label study
Not Applicable
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000023109
- Lead Sponsor
- Tokyo Women's Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
- Patients with a history of hypersensitivity (including contact dermatitis) to any ingredient contained in the study drugs - Patients with infections with no available effective antimicrobial drugs or with deep seated mycosis - Patients with tuberculosis - Respiratory infection, judged by the investigator as an infection affecting the asthma, within 8 weeks prior to enrollment - Use of any beta-blocking agents - Treatment with oral, parenteral or rectal steroids within 30 days prior to enrollment - Any significant disease or disorder judged by the investigator - Current or previous with a smoking
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method